Selection of dialysis methods for end-stage kidney disease patients with diabetes
- PMID: 39280188
- PMCID: PMC11372645
- DOI: 10.4239/wjd.v15.i9.1862
Selection of dialysis methods for end-stage kidney disease patients with diabetes
Abstract
The increasing prevalence of diabetes has led to a growing population of end-stage kidney disease (ESKD) patients with diabetes. Currently, kidney transplantation is the best treatment option for ESKD patients; however, it is limited by the lack of donors. Therefore, dialysis has become the standard treatment for ESKD patients. However, the optimal dialysis method for diabetic ESKD patients remains controversial. ESKD patients with diabetes often present with complex conditions and numerous complications. Furthermore, these patients face a high risk of infection and technical failure, are more susceptible to malnutrition, have difficulty establishing vascular access, and experience more frequent blood sugar fluctuations than the general population. Therefore, this article reviews nine critical aspects: Survival rate, glucose metabolism disorder, infectious complications, cardiovascular events, residual renal function, quality of life, economic benefits, malnutrition, and volume load. This study aims to assist clinicians in selecting individualized treatment methods by comparing the advantages and disadvantages of hemodialysis and peritoneal dialysis, thereby improving patients' quality of life and survival rates.
Keywords: Diabetes; Dialysis methods selection; End-stage kidney disease; Hemodialysis; Peritoneal dialysis.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
References
-
- Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398:786–802. - PubMed
-
- Kuehn BM. End-stage Kidney Disease Doubles. JAMA. 2022;327:1540. - PubMed
-
- Kleinaki Z, Kapnisi S, Theodorelou-Charitou SA, Nikas IP, Paschou SA. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update. Hormones (Athens) 2020;19:467–476. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
